← Back to Search

Risk Score

Risk Reduction Intervention for Iatrogenic Disease (AGING Trial)

N/A

Recruiting

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Baseline medication risk score of 20 or more

Hospital admission for at least 48 hours

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at time of intervention

Awards & highlights

AGING Trial Summary

This trial will test whether the MedWise Risk Score can help identify which patients are at high risk for readmission and target them for interventions.

Who is the study for?

This trial is for older adults who were in the hospital for at least 2 days, have a high medication risk score (20+), and are taking 5 or more medications upon leaving the hospital. It's not for those who left the hospital against advice, passed away during their stay, live far from the facility, or went to hospice care.Check my eligibility

What is being tested?

The study tests if using MedWise Risk Score™ to guide treatment can lower this score and reduce chances of being readmitted within 30 days after discharge. High-risk patients will receive special attention to adjust their meds.See study design

What are the potential side effects?

Since this intervention involves adjusting existing medications rather than testing new ones, side effects will vary based on changes made to each patient's medication regimen.

AGING Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My medication risk score is 20 or higher.

Select...

I have been admitted to the hospital for at least 48 hours.

Select...

I was prescribed 5 or more medications when I left the hospital.

AGING Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days after hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days after hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of individuals with an emergency department visit or hospital readmission

Secondary outcome measures

Difference in score between patients aged older and younger than 65 years

AGING Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Discharge medication regimen instructions will be provided upon discharge after being assessed using the MWRS, optimized, and assessed by the prescriber.

Group II: Standard of CareActive Control1 Intervention

Discharge medication regimen instructions will be provided upon discharge after being assessed by the prescriber.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

63,432 Total Patients Enrolled

1 Trials studying Iatrogenic Disease

80 Patients Enrolled for Iatrogenic Disease

Media Library

MedWise Risk Score™ (Risk Score) Clinical Trial Eligibility Overview. Trial Name: NCT05017948 — N/A

Iatrogenic Disease Research Study Groups: Intervention, Standard of Care

Iatrogenic Disease Clinical Trial 2023: MedWise Risk Score™ Highlights & Side Effects. Trial Name: NCT05017948 — N/A

MedWise Risk Score™ (Risk Score) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05017948 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study including participants over 45 years of age?

"This research initiative is recruiting participants over the age of consent and below 90 years old."

Answered by AI

What credentials are necessary to be eligible for this trial?

"This medical trial seeks 800 participants aged 18 to 90 who have acquired an iatrogenic illness. In addition, potential volunteers must have been hospitalized for a minimum of 48 hours and possess a baseline medication risk score of 20 or higher."

Answered by AI

How many participants have signed up for this research trial thus far?

"Correct. According to the information posted on clinicaltrials.gov, this medical trial is still recruiting participants after its initial post date of September 15th 2021 and subsequent update on October 25th 2021. 800 people are required for this particular study at a single site location."

Answered by AI

Are there any opportunities for people to sign up for this medical experiment?

"According to the records found on clinicaltrials.gov, this investigation is still actively recruiting patients since its inception in September 15th 2021 and last update on October 25th 2021."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

Luigi Brunetti 2021. "Alleviating Geriatric Inpatients' Medication-related Iatrogenesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05017948.